BDO Wealth Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

BDO Wealth Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,000	Closed	–	–	732
2019 Q1	$0	Buy	+4,000	New	+$1.02K	﹤0.01%	691
2018 Q4	–	Sell	-4,000	Closed	-$7K	–	653
2018 Q3	$7K	Hold	4,000	–	–	﹤0.01%	488
2018 Q2	$7K	Hold	4,000	–	–	﹤0.01%	493
2018 Q1	$7K	Buy	+4,000	New	+$8.45K	﹤0.01%	421
2017 Q3	–	Sell	-2,500	Closed	-$11K	–	572
2017 Q2	$11K	Buy	+2,500	New	+$10.3K	﹤0.01%	368

BDO Wealth Advisors's SGYP Position: Q2 2019 in Review

BDO Wealth Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2019, closing a stake of 4,000 shares.

BDO Wealth Advisors first reported a position in SGYP in Q2 2017 and held it in 5 quarters. The position peaked at $11K in Q2 2017. 2 funds tracked by Wall St. Rank hold SGYP as of Q2 2019.

BDO Wealth Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2019 after selling out during the quarter.
BDO Wealth Advisors sold 4,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2019.
BDO Wealth Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2017 and held it in 5 quarters.
BDO Wealth Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $11K in Q2 2017.
2 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2019.

Based on BDO Wealth Advisors's 13F filing for Q2 2019, filed 9 Aug 2019.